missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-10 R beta Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 874-RB-100
Additional Details : Weight : 0.00970kg
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human IL 28 R alpha/IFN lambda R1 Fc Chimera (Catalog # 5260-MR ) is immobilized at 5.00 μg/mL (100 μL/well), the concentration of Recombinant Human IL-10 R beta Fc Chimera that produces 50% of the optimal binding response is found to be approximately 0.300-3.00 μg/mL.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 51 kDa (monomer) | |
| 100μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 3588 | |
| IL-10 R beta Fc Chimera | |
| Mouse myeloma cell line,NS0-derived human IL-10 R beta protein, (N-terminus) Human IL-10 R beta (Met20-Ser220) Accession &Num; Q08334 DIEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |